Janux Therapeutics Inc (JANX) Stock Price, Quote & News

Company Profile

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer. Its clinical candidates include JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer and the vasculature of other tumors; and JANX008, a...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 751 4493

Website: www.januxrx.com

Address:

10955 Vista Sorrento Parkway, Suite 200, San Diego, United States

RainMan_17 Dec. 6 at 4:51 PM

$JANX another analyst reaffirms Buy Rating @ $60PT https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-their-buy-rating-for-janux-therapeutics-inc-janx-blurbs

0 · Reply

Optionking828 Dec. 6 at 4:49 PM

$JANX Type of situation where you remind yourself…. Why you hate pharma stocks

1 · Reply

RockitMann Dec. 6 at 2:04 PM

$JANX Same chart as VKTX. Their stock also plummeted 50% after they published results earlier this summer. They have also now recovered to their pre-crash shareprice. This is all part of "their" games.

1 · Reply

MightyInvesTHOR Dec. 6 at 10:49 AM

$JANX next catalyst is coming before the year ends with Janx008, The update will focus on the recommended Phase 2 dose (RP2D), and most importantly, efficacy data (Objective Response Rate, or ORR) in different tumor types (e.g., CRC, NSCLC). Positive data would validate the platform's broader application and could significantly boost the stock. And also remember we also have another pre clinical on the pipelne, the trop2 which targets solid tumor. Either way this is a billion dollar biotech just the ip alone. Got a lot of cash to burn to do all of this for 2 yrs. So hold your shares.

0 · Reply

Super_Marioo Dec. 5 at 11:44 PM

$JANX - it’s been 3 days. the dust has not settled on this one yet but now leaning toward a positive sentiment. I will allow another few days in case a hedge fund decides to exit resulting in a pullback toward or under $15.

0 · Reply

putsbydayhumanbynight Dec. 5 at 9:22 PM

$JANX when do we hit citadels pt? I am thinking march.

1 · Reply

bizness1957 Dec. 5 at 9:20 PM

$JANX red to green candle …

0 · Reply

RainMan_17 Dec. 5 at 9:10 PM

$JANX Daily Analysis: reversed a weak morning and closed strong, reclaiming VWAP and the SMA with a clear late-day surge in volume. RSI rising into the mid-60s, a bullish MACD crossover, and a TTM Squeeze firing long all confirm strengthening momentum. Price defended $16 and pushed into the close, signaling buyers back in control. Unless news disrupts the setup, the chart favors a continuation move higher with upside into the $16.80–$17.10 range into Monday.

1 · Reply

waxonwacksoff Dec. 5 at 9:08 PM

$JANX Had to open a position here this afternoon. Looks like nothing but upside.

0 · Reply

ThePain Dec. 5 at 9:05 PM

$JANX why they covered on Friday?

1 · Reply

Options Exercise: Janux Executive Sells 16,665 Shares for $501,000

Dec 2, 2025, 10:58 AM EST - 4 days ago

Janux Therapeutics Stock Hits 52-Week Low After Trial Update

Dec 2, 2025, 10:50 AM EST - 4 days ago

Janux dives as gaps in prostate cancer study data worry investors

Dec 2, 2025, 8:41 AM EST - 4 days ago

Signet Jewelers, Janux Therapeutics, BW LPG And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

BWLP SIG

Dec 2, 2025, 8:30 AM EST - 4 days ago

Janux Therapeutics Stock Craters After ‘Positive' Cancer Drug Trial Data. Why It's Down 41%.

Dec 1, 2025, 11:13 PM EST - 5 days ago

Janux Therapeutics, Inc. (JANX) Shareholder/Analyst Call Transcript

Dec 1, 2025, 4:05 PM EST - 5 days ago

Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC

Nov 24, 2025, 8:00 AM EST - 12 days ago

Janux Therapeutics to Host Virtual Event Discussing Updated Phase 1a and Phase 1b Clinical Data for JANX007 in mCRPC

Nov 6, 2025, 4:01 PM EST - 4 weeks ago

Janux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights

Aug 7, 2025, 4:43 PM EDT - 4 months ago

Janux (JANX) R&D Soars Revenue Misses

Aug 7, 2025, 4:01 PM EDT - 4 months ago

Janux Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 5, 2025, 4:05 PM EDT - 4 months ago

Janux Therapeutics Announces Clinical Milestone Achievement in TRACTr Collaboration With Merck

Jul 31, 2025, 12:01 AM EDT - 4 months ago

Janux: A High-Risk/High-Reward Bet On Oncology And Autoimmune Therapies Backed By $1B In Cash

Jul 24, 2025, 4:05 PM EDT - 4 months ago

Janux Therapeutics Highlights Pipeline Progress and Best-in-Class Potential of Novel Bispecific Platform for Autoimmune Diseases at Virtual R&D Day

Jul 17, 2025, 4:30 PM EDT - 5 months ago

Janux Therapeutics to Host Virtual R&D Day on July 24, 2025

May 15, 2025, 8:00 AM EDT - 7 months ago

Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer

May 8, 2025, 4:01 PM EDT - 7 months ago

Janux Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights

May 5, 2025, 8:30 AM EDT - 7 months ago

Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates

Apr 5, 2025, 8:14 AM EDT - 8 months ago

Janux Therapeutics: Buying For The Promising Pipeline, Holding For The Buyout

Feb 27, 2025, 4:01 PM EST - 10 months ago

Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Jan 24, 2025, 4:01 PM EST - 11 months ago

Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer

Jan 8, 2025, 9:00 AM EST - 11 months ago

Janux Therapeutics: mCRPC TAM And Promising JANX007's Phase 1 Data

Jan 2, 2025, 11:46 PM EST - 1 year ago

Best-Performing Stocks Of 2024

APP BYRN CADL DAVE INOD LUNR MSTR

Dec 6, 2024, 7:43 PM EST - 1 year ago

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters' Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million

Dec 4, 2024, 11:12 PM EST - 1 year ago

Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Dec 4, 2024, 6:23 PM EST - 1 year ago

Why Janux Therapeutics Crushed the Market Today

Dec 3, 2024, 4:01 PM EST - 1 year ago

Janux Therapeutics Announces Proposed Public Offering

Dec 3, 2024, 10:49 AM EST - 1 year ago

Janux Therapeutics' Prostate Cancer Trial Data Exceeds Investor Expectations: Analyst

Dec 3, 2024, 10:39 AM EST - 1 year ago

Janux Therapeutics Stock Soars 70% on Prostate Cancer Drug Trial Results

Dec 2, 2024, 4:30 PM EST - 1 year ago

Janux Announces Doses Selected for Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC

Nov 25, 2024, 9:00 AM EST - 1 year ago

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies

Nov 19, 2024, 1:23 AM EST - 1 year ago

Janux Therapeutics: Believable Theory, Strong Early Data, Needs Confirmation

Nov 6, 2024, 4:01 PM EST - 1 year ago

Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Aug 7, 2024, 4:01 PM EDT - 1 year ago

Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

Jul 22, 2024, 4:01 PM EDT - 1 year ago

Janux Therapeutics Announces Updates to Board of Directors

Jun 26, 2024, 8:32 AM EDT - 1 year ago

Janux Therapeutics: Promising T-Cell Engager Platform In Cancer Therapy

May 7, 2024, 4:01 PM EDT - 1 year ago

Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Apr 30, 2024, 12:06 AM EDT - 1 year ago

Janux Therapeutics (JANX) stock has gone parabolic: what next?

Apr 12, 2024, 5:40 AM EDT - 1 year ago

Why Janux Therapeutics Stock Is Crushing It This Week

Apr 11, 2024, 9:00 AM EDT - 1 year ago

Janux Therapeutics: A Prime Target In Cancer Care's M&A Game

Apr 10, 2024, 6:39 PM EDT - 1 year ago

Why Janux Therapeutics Stock Soared as the Market Sagged Today

Apr 2, 2024, 2:10 AM EDT - 1 year ago

VKTX, JANX and these biotech stocks are surging in 2024

ARQT VKTX AMLX MCRB RAPT RVNC

Mar 20, 2024, 1:44 PM EDT - 1 year ago

Cancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst - Janux Therapeutics (NASDAQ:JANX)

Mar 15, 2024, 9:45 AM EDT - 1 year ago

2 Stocks That Have More Than Tripled This Year: Are They Buys?

VKTX

Mar 8, 2024, 4:01 PM EST - 1 year ago

Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Mar 2, 2024, 6:56 AM EST - 1 year ago

After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy?

Feb 29, 2024, 1:22 AM EST - 1 year ago

Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Feb 27, 2024, 5:15 PM EST - 1 year ago

Janux: Additional Opportunity With JANX007 Dosing Update In The 2nd Half Of 2024

Feb 27, 2024, 5:00 PM EST - 1 year ago

Janux Therapeutics Announces Proposed Public Offering of Common Stock

Feb 27, 2024, 8:38 AM EST - 1 year ago

Janux Therapeutics surges as trial data for prostate cancer therapy shows promise

RainMan_17 Dec. 6 at 4:51 PM

$JANX another analyst reaffirms Buy Rating @ $60PT https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-their-buy-rating-for-janux-therapeutics-inc-janx-blurbs

0 · Reply

Optionking828 Dec. 6 at 4:49 PM

$JANX Type of situation where you remind yourself…. Why you hate pharma stocks

1 · Reply

RockitMann Dec. 6 at 2:04 PM

1 · Reply

MightyInvesTHOR Dec. 6 at 10:49 AM

0 · Reply

Super_Marioo Dec. 5 at 11:44 PM

0 · Reply

putsbydayhumanbynight Dec. 5 at 9:22 PM

$JANX when do we hit citadels pt? I am thinking march.

1 · Reply

bizness1957 Dec. 5 at 9:20 PM

$JANX red to green candle …

0 · Reply

RainMan_17 Dec. 5 at 9:10 PM

1 · Reply

waxonwacksoff Dec. 5 at 9:08 PM

$JANX Had to open a position here this afternoon. Looks like nothing but upside.

0 · Reply

ThePain Dec. 5 at 9:05 PM

$JANX why they covered on Friday?

1 · Reply

Et7806 Dec. 5 at 8:57 PM

$JANX

0 · Reply

EvieA_Knltw42 Dec. 5 at 8:51 PM

$JANX catalyst-driven biotech, capable of multi-day momentum if data hits

0 · Reply

RainMan_17 Dec. 5 at 8:35 PM

$SMX need a #shortsqueeze at $JANX👀🤑 News of JANX008 coming any day now (scheduled for Q4 release) along with increasing rumors of a $MRK buy out. Stock currently trading BELOW Net Cash - insane. Easy money for those who jump in now. Professor GPT agrees -

0 · Reply

RainMan_17 Dec. 5 at 8:34 PM

$TGL need a #shortsqueeze at $JANX 👀🤑 News of JANX008 coming any day now (scheduled for Q4 release) along with increasing rumors of a $MRK buy out. Stock currently trading BELOW Net Cash - insane. Easy money for those who jump in now. Professor GPT agrees -

0 · Reply

RainMan_17 Dec. 5 at 8:34 PM

$WHLR need a #shortsqueeze at $JANX 👀🤑 News of JANX008 coming any day now (scheduled for Q4 release) along with increasing rumors of a $MRK buy out. Stock currently trading BELOW Net Cash - insane. Easy money for those who jump in now. Professor GPT agrees -

0 · Reply

ThePain Dec. 5 at 8:25 PM

$JANX I think this happened, they already shared data during market hrs, many retailers bought calls, they had no choice to push it down,to kill calls , with some bullshit reason.

1 · Reply

ThePain Dec. 5 at 8:23 PM

$JANX retailers not even .5% in this, it's all tutes manipulation, and will up when they wish it to

1 · Reply

Irakli2508 Dec. 5 at 8:18 PM

$JANX

0 · Reply

RainMan_17 Dec. 5 at 7:52 PM

$TGL need a #shortsqueeze at $JANX News of JANX008 coming any day now (scheduled for Q4 release) along with increasing rumors of a $MRK buy out. Stock currently trading BELOW Net Cash - insane. Easy money for those who jump in now. $JANX Professor GPT agrees -

0 · Reply

RainMan_17 Dec. 5 at 7:51 PM

$CAPR need a #shortsqueeze at $JANX News of JANX008 coming any day now (scheduled for Q4 release) along with increasing rumors of a $MRK buy out. Stock currently trading BELOW Net Cash - insane. Easy money for those who jump in now. $JANX Professor GPT agrees -

2 · Reply

RainMan_17 Dec. 5 at 7:48 PM

$NVO need a #shortsqueeze at $JANX Beyond oversold. News of JANX008 coming any day now (scheduled for Q4 release) along with increasing rumors of a $MRK buy out. Stock currently trading BELOW Net Cash - insane. Easy money for those who jump in now. Professor GPT agrees -

0 · Reply

Captenotwo Dec. 5 at 7:46 PM

$JANX 1000 shares now. Wetting my beak here. Cap

0 · Reply

Market Cap	993.04M
Revenue (ttm)	10.59M
Net Income (ttm)	-68.99M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-651.46%
Debt to Equity Ratio	0.00

Volume	2,141,800
Avg Vol	1,575,962
Day's Range	N/A - N/A
Shares Out	60.15M
Stochastic %K	5%
Beta	2.82
Analysts	Strong Sell
Price Target	$66.88